- Report
- October 2023
- 146 Pages
Global
From €4007EUR$4,150USD£3,393GBP
- Report
- September 2019
- 40 Pages
United States
From €2505EUR$2,595USD£2,122GBP
- Report
- September 2019
- 40 Pages
Russia
From €2505EUR$2,595USD£2,122GBP
- Report
- September 2019
- 40 Pages
Ireland
From €2505EUR$2,595USD£2,122GBP
- Report
- September 2019
- 40 Pages
Germany
From €2505EUR$2,595USD£2,122GBP
- Report
- September 2019
- 40 Pages
France
From €2505EUR$2,595USD£2,122GBP
- Report
- September 2019
- 40 Pages
China
From €2505EUR$2,595USD£2,122GBP
- Report
- September 2019
- 40 Pages
Brazil
From €2505EUR$2,595USD£2,122GBP
- Report
- September 2019
- 80 Pages
Africa
From €3664EUR$3,795USD£3,103GBP
- Report
- April 2024
- 132 Pages
Global
From €917EUR$950USD£777GBP
- Report
- January 2024
- 132 Pages
Global
From €917EUR$950USD£777GBP
- Report
- November 2021
- 1032 Pages
Global
From €4828EUR$5,000USD£4,088GBP
- Report
- July 2021
- 235 Pages
Global
From €3584EUR$3,712USD£3,035GBP
- Report
- September 2023
- 140 Pages
Global
From €2896EUR$2,999USD£2,452GBP
- Book
- September 2022
- 480 Pages
- Book
- November 2007
- 694 Pages
The Cardiac Marker market is a segment of the Pharmaceuticals industry that focuses on the development and production of drugs and other treatments for cardiovascular diseases. Cardiac markers are substances that are released into the bloodstream when the heart is damaged or stressed. These markers can be used to diagnose and monitor the progression of cardiovascular diseases, such as heart attack, stroke, and congestive heart failure. The market is driven by the increasing prevalence of cardiovascular diseases, the growing demand for early diagnosis and treatment, and the development of new technologies.
The Cardiac Marker market is highly competitive, with a number of large and small companies operating in the space. Some of the major players in the market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more